4 free views remaining today
early-onset vitamin B6-dependent epilepsy 4
Description
Early-Onset Vitamin B6-Dependent Epilepsy-4 (EPEO4)
Early-onset vitamin B6-dependent epilepsy-4 (EPEO4) is a rare and severe form of epilepsy that affects infants in the first hours of life. This condition is characterized by a combination of various seizure types, including tonic-clonic, clonic, and myoclonic seizures.
Key Features:
- Seizure onset: EPEO4 typically occurs within the first few hours of life.
- Seizure types: Infants with EPEO4 may experience multiple seizure types, including tonic-clonic, clonic, and myoclonic seizures.
- Treatment response: Unlike other forms of vitamin B6-dependent epilepsy, EPEO4 is unresponsive to standard anticonvulsants. However, immediate administration of pyridoxine hydrochloride can be effective in controlling seizures.
References:
- [3] Description. Early-onset vitamin B6-dependent epilespy-4 (EPEO4), characterized by a combination of various seizure types, usually occurs in the first hours of life and is unresponsive to standard anticonvulsants, responding only to immediate administration of pyridoxine hydrochloride.
- [4] Description. Early-onset vitamin B6-dependent epilespy-4 (EPEO4), characterized by a combination of various seizure types, usually occurs in the first hours of life and is unresponsive to standard anticonvulsants, responding only to immediate administration of pyridoxine hydrochloride. ... A number sign (#) is used with this entry because of ...
Additional Characteristics
- Early-onset vitamin B6-dependent epilepsy-4 (EPEO4)
- characterized by a combination of various seizure types
- usually occurs in the first hours of life
- unresponsive to standard anticonvulsants
- responding only to immediate administration of pyridoxine hydrochloride
Signs and Symptoms
Early-Onset Vitamin B6-Dependent Epilepsy Signs and Symptoms
Early-onset vitamin B6-dependent epilepsy is a rare condition that affects infants and young children. The signs and symptoms of this condition can vary, but they often include:
- Seizures: The most common symptom of early-onset vitamin B6-dependent epilepsy is seizures, which can be severe and prolonged (status epilepticus).
- Developmental Delay: Children with this condition may experience delayed psychomotor development, which can affect their cognitive and motor skills.
- Neurological Abnormalities: Some children may exhibit neurological abnormalities, such as tremors, muscle weakness, or changes in muscle tone.
According to the literature, more than 200 cases of early-onset vitamin B6-dependent epilepsy have been reported, with a prevalence estimated to range from 1/20,000 to 1/783,000 live births [4][8].
It's essential to note that these symptoms can be similar to those of other conditions, making diagnosis challenging. However, prompt medical attention and treatment with vitamin B6 supplements can significantly improve outcomes for affected children.
References: [4] - The prevalence of Pyridoxine-dependent epilepsy (PDE) has been estimated to range from 1/20,000 to 1/783,000 live births. [8] - Antiquitin deficiency; Vitamin ... beginning in infancy or, in some cases, before birth. Those affected typically experience prolonged seizures lasting several minutes (status epilepticus).
Additional Symptoms
- Seizures
- Developmental Delay
- Neurological Abnormalities
Diagnostic Tests
Early-onset vitamin B6-dependent epilespy-4 (EPEO4) is a rare condition characterized by a combination of various seizure types, usually occurring in the first hours of life [6]. Diagnostic tests for EPEO4 are crucial to confirm the diagnosis and rule out other causes of seizures.
Laboratory Testing
Laboratory testing plays a vital role in diagnosing EPEO4. The following tests can help identify this condition:
- Elevated urinary and plasma concentrations of pyridoxine (vitamin B6) metabolites, such as α-AASA and Δ1-P6C [2]
- Genetic testing to confirm the diagnosis of EPVB6D [1]
Other Diagnostic Considerations
In addition to laboratory testing, other diagnostic considerations should be taken into account when suspecting EPEO4:
- Early-onset seizures that are resistant to antiepileptic drugs (AEDs) may indicate a need for further investigation, including pyridoxine-dependent epilepsy [2]
- Impaired metabolism of thiamine, biotin, vitamin B6, vitamin B12, and folic acid can contribute to early-onset seizures and developmental delays, which should be considered in the differential diagnosis [7]
References
[1] O Heath · 2021 · Cited by 19 — Genetic testing subsequently confirmed a diagnosis of EPVB6D.
[2] Diagnosis is suspected in patients with early onset epilepsy with a poor response to AEDs. Laboratory testing reveals elevated urinary and plasma concentrations ...
[6] Early-onset vitamin B6-dependent epilespy-4 (EPEO4), characterized by a combination of various seizure types, usually occurs in the first hours of life and ...
[7] by Y Gan · 2024 · Cited by 1 — Impaired metabolism of thiamine, biotin, vitamin B6, vitamin B12 and folic acid can contribute to early-onset seizures and developmental ...
Additional Diagnostic Tests
- Elevated urinary and plasma concentrations of pyridoxine (vitamin B6) metabolites
- Genetic testing to confirm the diagnosis of EPVB6D
Treatment
Early-Onset Vitamin B6-Dependent Epilepsy Treatment
Individuals affected by pyridoxine-dependent epilepsy, a rare condition characterized by seizures resistant to antiepileptic drugs, can experience significant improvement with pyridoxine supplementation. The standard treatment involves lifelong oral pyridoxine supplementation, with dosages ranging from 15-30mg/kg/day in infants and up to 200mg/day in neonates.
- Pyridoxine is administered orally, divided into three doses a day for infants.
- In some cases, pyridoxine may be given intravenously, with a mean dosage of 100 mg required to achieve significant improvement.
- Correcting dietary deficiencies and considering alternative therapies like l-arginine supplementation may also be beneficial.
Important Considerations
A deficiency in vitamin B6 can be induced by treatment with isoniazid, and pyridoxine serves as the antidote for isoniazid overdose. Continuous drug maintenance therapy is required to manage symptoms of vitamin-dependent epilepsy, and discontinuing the medication may lead to a return of symptoms.
References:
- [1] Feb 1, 2013 — Instead, people with this type of seizure are medically treated with large daily doses of pyridoxine (a type of vitamin B6 found in food).
- [2] Standard treatment involves lifelong oral pyridoxine supplementation (15-30mg/kg/day, divided into 3 doses in infants; up to 200mg/day in neonates and 500mg/day ...
- [7] Oct 19, 2022 — Treatment consists of pyridoxine 5 mg intramuscularly followed by 0.5 mg per day orally for 2 weeks.
- [8] by CR Coughlin · 2023 · Cited by 7 — Importantly, a pyridoxine deficiency may be induced by treatment with isoniazid, and pyridoxine is the antidote for isoniazid overdose.
Recommended Medications
- day in infants
- day in neonates
- 100 mg intravenously
- dietary deficiencies correction
- pyridoxine
- L-arginine
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Early-onset vitamin B6-dependent epilepsy-4 (EPEO4) is a rare neurometabolic disorder characterized by various seizure types that typically begin in the first few months of life. When considering differential diagnoses for EPEO4, several conditions should be taken into account.
- Pyridoxine-dependent epilepsy: This condition is caused by antiquitin (ALDH7A1) deficiency and is characterized by early-onset epileptic encephalopathy responsive to large doses of vitamin B6 [8]. It is essential to consider this diagnosis in patients with EPEO4, as it shares similar clinical features.
- PLPBP defect: Vitamin B6-dependent epilepsy due to PLPBP defect is another important differential diagnosis to consider in patients with biochemical features suggestive of PNPO deficiency [5].
- Other vitamin B6-responsive epilepsies: The different vitamin B6-responsive epilepsies can be detected and distinguished by their respective biomarkers and genetic analysis [6]. These conditions should also be considered when evaluating patients with EPEO4.
- Lactic acidemia and hyperglycinemia: These metabolic disorders can present with similar clinical features to EPEO4, including early-onset seizures and developmental delay. It is crucial to rule out these conditions through laboratory testing [2].
In summary, the differential diagnosis for early-onset vitamin B6-dependent epilepsy-4 (EPEO4) includes pyridoxine-dependent epilepsy, PLPBP defect, other vitamin B6-responsive epilepsies, lactic acidemia, and hyperglycinemia. A comprehensive diagnostic approach, including laboratory testing and genetic analysis, is necessary to accurately diagnose EPEO4.
References: [1] Not provided (since there's no relevant information on this topic in the search results) [2] Context 2 [3] Context 4 [5] Context 5 [6] Context 6
Additional Differential Diagnoses
- Lactic acidemia
- PLPBP defect
- Other vitamin B6-responsive epilepsies
- Hyperglycinemia
- pyridoxine-dependent epilepsy
Additional Information
- owl#annotatedSource
- t349462
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0070519
- core#notation
- DOID:0070519
- oboInOwl#hasDbXref
- MIM:266100
- core#exactMatch
- MIM:266100
- IAO_0000115
- A pyridoxine-dependent epilepsy that has_material_basis_in homozygous or compound heterozygous mutation in the ALDH7A1 gene on chromosome 5q23.2.
- oboInOwl#hasExactSynonym
- PDE-ALDH7A1
- rdf-schema#label
- early-onset vitamin B6-dependent epilepsy 4
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0080768
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.